These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
300 related items for PubMed ID: 16146539
1. Dapsone for chronic idiopathic thrombocytopenic purpura in children and adults--a report on 90 patients. Damodar S, Viswabandya A, George B, Mathews V, Chandy M, Srivastava A. Eur J Haematol; 2005 Oct; 75(4):328-31. PubMed ID: 16146539 [Abstract] [Full Text] [Related]
2. Efficacy and safety of dapsone as a second-line treatment in non-splenectomized adults with immune thrombocytopenic purpura. Vancine-Califani SM, De Paula EV, Ozelo MC, Orsi FL, Fabri DR, Annichino-Bizzacchi JM. Platelets; 2008 Nov; 19(7):489-95. PubMed ID: 18979360 [Abstract] [Full Text] [Related]
3. Twenty years experience with treatment of idiopathic thrombocytopenic purpura in a single department: results in 490 cases. Schiavotto C, Rodeghiero F. Haematologica; 1993 Nov; 78(6 Suppl 2):22-8. PubMed ID: 8039754 [Abstract] [Full Text] [Related]
4. Dapsone in treatment of chronic idiopathic thrombocytopenic purpura in adults. Dutta TK, Goel A, Ghotekar LH, Hamide A, Badhe BA, Basu D. J Assoc Physicians India; 2001 Apr; 49():421-5. PubMed ID: 11762611 [Abstract] [Full Text] [Related]
5. Dapsone for immune thrombocytopenic purpura in children and adults. Patel AP, Patil AS. Platelets; 2015 Apr; 26(2):164-7. PubMed ID: 24512442 [Abstract] [Full Text] [Related]
6. Dapsone treatment in a girl with severe chronic thrombocytopenic purpura. Does it work? Do not touch it! Pusiol A, Nocerino A, Passone E, Tenore A. Minerva Pediatr; 2012 Oct; 64(5):545-7. PubMed ID: 22992536 [Abstract] [Full Text] [Related]
7. Outcome of chronic idiopathic thrombocytopenic purpura in children. Bansal D, Bhamare TA, Trehan A, Ahluwalia J, Varma N, Marwaha RK. Pediatr Blood Cancer; 2010 Mar; 54(3):403-7. PubMed ID: 19908301 [Abstract] [Full Text] [Related]
8. Dapsone salvage therapy for adult patients with immune thrombocytopenia relapsed or refractory to steroid and rituximab. Zaja F, Marin L, Chiozzotto M, Puglisi S, Volpetti S, Fanin R. Am J Hematol; 2012 Mar; 87(3):321-3. PubMed ID: 22190262 [Abstract] [Full Text] [Related]
9. Role of splenectomy in chronic idiopathic thrombocytopenic purpura. Srinivasan S, Sabapathy K, Bharadwaj TP, Sethuraman S. J Assoc Physicians India; 2003 Feb; 51():159-62. PubMed ID: 12725258 [Abstract] [Full Text] [Related]
10. Pulsed intravenous high-dose dexamethasone in adults with chronic idiopathic thrombocytopenic purpura. Stasi R, Brunetti M, Pagano A, Stipa E, Masi M, Amadori S. Blood Cells Mol Dis; 2000 Dec; 26(6):582-6. PubMed ID: 11112391 [Abstract] [Full Text] [Related]
11. Low rate of long-lasting remissions after successful treatment of immune thrombocytopenic purpura with rituximab. Schweizer C, Reu FJ, Ho AD, Hensel M. Ann Hematol; 2007 Oct; 86(10):711-7. PubMed ID: 17622529 [Abstract] [Full Text] [Related]
12. Clinical efficacy and safety of Flebogammadif, a new high-purity human intravenous immunoglobulin, in adult patients with chronic idiopathic thrombocytopenic purpura. Julia A, Kovaleva L, Loria S, Alberca I, Hernandez F, Sandoval V, Sierra J, Vidaller A, Ayguasanosa J, Carretero M. Transfus Med; 2009 Oct; 19(5):260-8. PubMed ID: 19747289 [Abstract] [Full Text] [Related]
13. Efficacy and response to intravenous anti-D immunoglobulin in chronic idiopathic thrombocytopenic purpura. Ramadan KM, El-Agnaf M. Clin Lab Haematol; 2005 Aug; 27(4):267-9. PubMed ID: 16048495 [Abstract] [Full Text] [Related]
14. High-dose dexamethasone as a first- and second-line treatment of idiopathic thrombocytopenic purpura in adults. Borst F, Keuning JJ, van Hulsteijn H, Sinnige H, Vreugdenhil G. Ann Hematol; 2004 Dec; 83(12):764-8. PubMed ID: 15309522 [Abstract] [Full Text] [Related]
15. The response to treatment in chronic idiopathic thrombocytopenic purpura (ITP). Eldor A, Gillis S, Ben-Yehuda D. Southeast Asian J Trop Med Public Health; 1993 Dec; 24 Suppl 1():69-70. PubMed ID: 7886611 [Abstract] [Full Text] [Related]
16. [Diaminodiphenyl sulfone therapy for refractory idiopathic thrombocytopenic purpura--long-term effectiveness and possible mechanisms]. Hirasawa A, Sato T, Kawabuchi Y, Nishikawa T, Chiba S, Wakabayashi Y. Rinsho Ketsueki; 1999 Oct; 40(10):1068-73. PubMed ID: 10565223 [Abstract] [Full Text] [Related]
17. Absence of platelet recovery following Helicobacter pylori eradication in childhood chronic idiopathic thrombocytopenic purpura: a multi-center randomized controlled trial. Treepongkaruna S, Sirachainan N, Kanjanapongkul S, Winaichatsak A, Sirithorn S, Sumritsopak R, Chuansumrit A. Pediatr Blood Cancer; 2009 Jul; 53(1):72-7. PubMed ID: 19301380 [Abstract] [Full Text] [Related]
18. A population-based, multisite cohort study of the predictors of chronic idiopathic thrombocytopenic purpura in children. Glanz J, France E, Xu S, Hayes T, Hambidge S. Pediatrics; 2008 Mar; 121(3):e506-12. PubMed ID: 18310170 [Abstract] [Full Text] [Related]
19. Experience with high dose dexamethasone in the treatment of chronic symptomatic immune thrombocytopaenia. Van Riet FA, Wessels G, Hesseling PB. East Afr Med J; 1999 Oct; 76(10):571-4. PubMed ID: 10734508 [Abstract] [Full Text] [Related]
20. Interferon-alpha therapy for refractory idiopathic thrombocytopenic purpura in children. Yeşilipek MA, Yeğin O. Turk J Pediatr; 1997 Oct; 39(2):173-6. PubMed ID: 9223914 [Abstract] [Full Text] [Related] Page: [Next] [New Search]